The ATS 2025 International Conference offers a robust scientific program highlighting cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several Postgraduate Courses, Scientific Symposia, and Meet the Expert Sessions addressing new developments and considerations in the fields of allergy and immunology, as listed below. A curated list of clinical and scientific sessions related to these topics is also available on the ATS365 platform. For more information on these and other sessions to be presented May 16–21 in San Francisco, visit the online Advance Program.
- A1 CLINICAL YEAR IN REVIEW
- A102 PHYSIOLOGY AND IMAGING IN AIRWAY DISEASE
- A107 NOVEL THERAPIES AND MOLECULAR PATHWAYS IN COPD, AATD, AND AIRWAY REGENERATION
- A108 ALL THAT’S WICKED IN ASTHMA
- A12 IMPLEMENTING PREVENTATIVE AND BEHAVIORAL HEALTH INTERVENTIONS IN PULMONARY MEDICINE
- A18 BEST TRIALS IN PULMONARY REHABILITATION
- A19 COMING INTO FOCUS: NOVEL APPROACHES TO CAPTURE ASTHMA
- A22 BREAK ON THROUGH: AIRWAY EPITHELIAL BARRIER IN INFLAMMATION AND INJURY
- A23 MICROBIAL MAESTROS: ORCHESTRATION OF HOST-PATHOGEN INTERACTION
- A30 BIOMARKERS, PREDICTORS, AND MODIFIERS OF PEDIATRIC PULMONARY OUTCOMES
- A31 THE EVOLVING LANDSCAPE OF BRONCHOPULMONARY DYSPLASIA: MAKING STRIDES
- A32 IT’S NOT EASY BEING WHEEZY: ASTHMA AND COPD CLINICAL STUDIES
- A33 BIOMARKER WINDOW INTO LUNG DISEASE
- A34 WINNING THE BIOLOGIC BATTLE IN ASTHMA AND COPD
- A38 MEDICAL EDUCATION AND WELLNESS
- A63 PEDIATRIC ASTHMA, CHRONIC COUGH, AND ENVIRONMENTAL LUNG DISEASES
- A64 EVALUATION AND TESTING FOR PEDIATRIC LUNG DISEASES
- A68 EXPANDING HORIZONS IN PULMONARY REHABILITATION: NOVEL APPLICATIONS, OUTCOMES, AND INNOVATIONS
- A70 GENE EXPRESSION, METABOLISM AND EPITHELIAL DYSFUNCTION IN AIRWAY DISEASES: FROM ASTHMA TO COPD
- A72 KNIVES OUT: SHARPENING TOOLS FOR UNDERSTANDING ASTHMA AND OTHER AIRWAY DISEASES
- A8 EMPHYSEMA ACROSS DISEASES: FLAWED (RE)GENERATION OR RAPID DESTRUCTION?
- A81 PEDIATRIC YEAR IN REVIEW
- A87 VIRTUAL PULMONARY REHABILITATION: CAN WE GET TO CONSENSUS? A PRO/CON DEBATE
- A88 EPIGENETICS: HOW EARLY LIFE EXPOSURES CONTRIBUTE TO LUNG DISEASE LATER IN LIFE
- A89 REVOLUTIONIZING RESPIRATORY DISEASE MANAGEMENT WITH MACHINE LEARNING AND AI INSIGHTS
- A93 BREATH OF HOPE: DECODING LUNG INJURY AND UNLOCKING TREATMENTS
- A98 EARLY EXPOSURES, LASTING IMPACTS: HOW PRENATAL AND CHILDHOOD EXPOSURES SHAPE RESPIRATORY HEALTH
- B1 CLINICAL YEAR IN REVIEW
- B101 FIXING BARRIERS: UNLOCKING TREATMENT MODALITIES IN INFLAMMATORY LUNG DISEASES
- B105 PULMONARY FUNCTION TESTING, IMAGING, AND DIAGNOSTIC TOOLS FOR PEDIATRIC PULMONARY DISEASES
- B108 INNOVATIVE INSIGHTS INTO LUNG INJURY: FROM INFLAMMATION TO BARRIER RESTORATION
- B14 FROM INFLAMMATION TO INFECTION: EXPLORING BREAKTHROUGHS IN AIRWAYS DISEASE
- B15 MACROPHAGES: THE PAC-MAN OF THE IMMUNE SYSTEM
- B17 THE POWER OF TEAM SCIENCE: INTERDISCIPLINARY APPROACHES TO PULMONARY AND CRITICAL CARE
- B18 BEST IN PEDIATRICS
- B21 EQUITY, EFFECTIVENESS AND EXPERIENCE IN PR
- B22 COPD: THE AGE OF OMICS
- B29 AIRWAY AND ALVEOLAR EPITHELIAL RESPONSES: FROM INJURY MECHANISMS TO REGENERATIVE POTENTIAL
- B32 LUNG-GEVITY: IMMUNE MODULATION IN LUNG INJURY
- B33 WHEEZING THROUGH THE MECHANISMS: UNPACKING ASTHMA’S SECRETS
- B34 BREATH-TAKING MECHANISMS IN COPD
- B35 ‘OMICS AND OUTCOMES: TRANSLATIONAL STUDIES ACROSS LUNG DISEASES
- B36 REPAIR MY BROKEN LUNGS
- B37 HEALING THE INFECTED LUNGS
- B38 LUNG DISEASE IN ZEBRAS: RATE AND AUTOIMMUNE CASE REPORTS
- B5 REMINISCENCE OF AN EARLIER LIFE – SHEDDING MECHANISTIC LIGHT ON THE TRANSGENERATIONAL IMPACT OF CIGARETTE SMOKE ON LUNG FUNCTION
- B51 BREATHLESS IN SAN FRANCISCO: AIRWAY COMPROMISE, PNEUMONIA, AND UNUSUAL LUNG DISEASE
- B59 SILENT ASSAULTS: LUNG DISEASE AND INFLAMMATION FROM DUST, FIRES, BLASTS, MILITARY DEPLOYMENT, AND THE WTC COLLAPSE
- B6 PRECISION MEDICINE IN SEVERE ASTHMA: LATE-BREAKING RESULTS FROM THE PRECISE TRIAL
- B60 ADVANCING PATIENT CARE: THE INTERCONNECTION OF TRAINING, PERSPECTIVES, AND CLINICAL RESULTS IN RESPIRATORY HEALTH
- B7 CLEAR SKIES OR HAZY HORIZONS: DEBATING PERSONAL POLLUTION CONTROL
- B8 PULMONARY VIRUS INFECTIONS ACROSS THE LIFESPAN
- B85 OBSTRUCTIVE AIRWAY AND LUNG DISEASE BEGINS IN THE WOMB
- B87 HOT TOPICS IN CHILDHOOD ASTHMA: RISK FACTORS, MANAGEMENT, AND REMISSION
- B90 UNSEEN YET CRITICAL: SMALL AIRWAYS IN CHRONIC AIRWAY DISEASES
- B94 UNRAVELING THE CODE OF ENVIRONMENTAL EXPOSURE: RESPONSE WITH EPIGENETICS AND OMICS
- B95 OMICS CONTINUE TO IDENTIFY MECHANISMS UNDERLYING CHILDHOOD LUNG DISEASES
- C1 CLINICAL YEAR IN REVIEW
- C100 MORNING SHOWS THE DAY: PERINATAL DETERMINANTS OF AIRWAY STRUCTURE AND FUNCTION
- C101 ASTHMA AND COPD EPIDEMIOLOGY, MANAGEMENT AND POLICY
- C108 OPTIMIZING THE IMPACT OF PULMONARY REHABILITATION
- C109 IMMUNE AND CELLULAR MECHANISMS DRIVING AIRWAY DISEASES: FROM INFLAMMATION TO METABOLISM
- C11 MICROPLASTICS AND THEIR IMPACT ON HEALTH
- C14 STRENGTHENING YOUR “-ABS”: CLINICAL THERAPEUTICS FOR INFLAMMATORY LUNG DISEASE
- C15 ‘OMICS ODYSSEY ACROSS LUNG DISEASES
- C16 ASTHMA TREATMENT, HEALTH SERVICES RESEARCH, AND DISPARITIES
- C19 UNCOVERING DEEP ROOTS: NEW MECHANISMS IN AIRWAY DISEASE
- C2 TYPE 2 INFLAMMATION IN COPD: A PRO AND CON DEBATE
- C22 BIG DATA AND TECHNOLOGY IN RESPIRATORY MEDICINE
- C27 GENETICS AND -OMICS TO PREDICT AND UNDERSTAND CHILDHOOD LUNG DISEASES
- C3 PEDIATRIC CLINICAL CHEST ROUNDS
- C32 CASE REPORTS: ASTHMA/COPD TREATMENT AND DISEASE PROGRESSION
- C33 LATE BREAKING AND LUNG SHAKING ABSTRACTS
- C53 CURRENT INSIGHTS INTO RISK, DIAGNOSIS, AND TREATMENT OF OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES
- C55 EXPOSED: INJURY AND CANCER FROM VAPING, MARIJUANA, SMOKE, AND WORKPLACE HAZARDS
- C7 NEXT STEPS: ENHANCING RESEARCH TRIALS IN PULMONARY REHABILITATION TO IMPROVE REAL WORLD IMPLEMENTATION
- C73 ENVIRONMENTAL STRESSORS AND MOLECULAR MECHANISMS DRIVING LUNG INJURY AND DISEASE PATHOGENESIS
- C74 CELLULAR DYNAMICS, ECM REGULATION, AND INNOVATIVE MODELS IN LUNG PATHOBIOLOGY
- C75 COPD: STRUCTURE AND FUNCTION
- C86 HOW NOVEL INFLAMMATORY INTERACTIONS IN ASTHMA CONTRIBUTE TO DISEASE AND SEVERITY
- C88 YES, A WHOLE SESSION ON MUCUS: LATEST RESEARCH INSIGHTS
- C89 FROM AIR TO AILMENTS: UNDERSTANDING THE IMPACT OF AIRBORNE POLLUTANTS AND PARTICULATE MATTER FROM DIFFERENT SOURCES ON HEALTH
- C94 BREATHING EASY: UNRAVELING THE MYSTERIES OF ASTHMA THROUGH TRANSLATIONAL STUDIES
- C97 CUTTING-EDGE ADVANCES IN PEDIATRIC LUNG DISEASES: FROM PREDICTION TO MANAGEMENT
- D1 CLINICAL YEAR IN REVIEW
- D101 DISCOVERY OMICS AND COMPUTATIONAL STRATEGIES IN LUNG DISEASE RESEARCH
- D109 THE NEW NORMAL? EARLY SIGNS OF CHRONIC LUNG DISEASE
- D11 LONG-TERM CONSEQUENCES OF RESPIRATORY VIRAL INFECTIONS AND CHRONIC PULMONARY DISEASES: LONG-COVID, ASTHMA, ILD AND LUNG TRANSPLANT
- D12 GUARDIAN OF THE AIRWAYS: UNVEILING THE ROLE OF EPITHELIUM IN IMMUNE REGULATION
- D16 INDOOR/OUTDOOR AIR POLLUTION: UNCOVERING DISPARITIES AND ADVANCING LUNG HEALTH
- D21 IMMUNOLOGICAL INSIGHTS IN LUNG INFLAMMATION AND REPAIR
- D27 CELLULAR MECHANISMS AND IMMUNE PATHWAYS UNDERLYING PEDIATRIC PULMONARY DISEASES
- D30 GOING WITH THE FLOW: ABNORMALITIES IN RESPIRATORY MECHANICS
- D7 TECHNOLOGICAL ADVANCEMENTS IN PEDIATRIC PULMONOLOGY: REMOTE DATA AND DECISION SUPPORT
- D8 25 YEARS OF SEVERE ASTHMA RESEARCH PROGRAM: DISCOVERIES AND BEYOND
- D85 RESPIRATORY MANIFESTATIONS OF ANCA-ASSOCIATED VASCULITIS: LESSONS FROM RECENTLY COMPLETED RCTS
- D86 COMMUNITY ENGAGEMENT FOR PULMONARY AND ENVIRONMENTAL HEALTH RESEARCH: LESSONS LEARNED FROM COMMUNITY PARTNERS, SITE ACCESS, AND RECRUITMENT
- D94 INROADS INTO NOVEL THERAPEUTICS AND DELIVERY APPROACHES FOR PEDIATRIC LUNG DISEASES
- D96 PNEUMONIA’S SECRET RECIPE: A PINCH OF MICROBIOME, A DASH OF HOST FACTORS, AND A SHOT OF VACCINE
- IPC3 Smoking and Vaping: Role of Respiratory Societies in Global Prevention
- IPC4 Quality Management of Chronic Respiratory Diseases in Resource-Constrained Countries
- MD1 RED JOURNAL IN ACTION 1: EARLY CAREER LUNG RESEARCH HIGHLIGHTS
- MD10 NEUTROPHILIC MECHANISMS OF INFLAMMATION, INJURY, AND REPAIR IN LUNG DISEASES
- MD12 LUNGMAP PHASE 3- NOVEL TECHNOLOGY, DATA SCIENCE, AND RESOURCES
- MD16 RED JOURNAL IN ACTION 2: AIRWAYS MEET NEUROSCIENCE PERSPECTIVES
- MD19 ONE BREATH, MANY SPECIES: TRANSLATIONAL APPLICATIONS OF LUNG DISEASES
- MD21 50 YEARS OF SUPPORTING LUNG RESEARCH: THE PARKER B. FRANCIS FELLOWSHIP
- MD23 NEW INSIGHTS INTO THE PATHOPHYSIOLOGY OF SEVERE ASTHMA
- MD27 UNDERSTANDING DISPARITIES IN CHILDHOOD ASTHMA USING NIH ENVIRONMENTAL INFLUENCES ON CHILD HEALTH OUTCOMES (ECHO) PROGRAM DATA: MULTICENTER APPROACHES
- MD28 HOW DO SHORT-LIVED LUNG INFECTIONS LEAD TO LONG-LASTING LUNG DAMAGE AND CHRONIC DISEASES?
- MD30 MICRO AND NANOPLASTICS HEALTH EFFECTS: WHAT WE KNOW OR DON’T
- MD37 BIOMARKER-DIRECTED THERAPIES FOR ASTHMA – LESSONS LEARNED IN THE PRECISE NETWORK
- MD8 THE DEVELOPMENT AND EVALUATION OF AN ASTHMA TRIGGERS TRAINING COURSE
- MTE18 PEDIATRIC AIRWAY SAMPLING: ARE WE DOING IT RIGHT?
- MTE2 MAKING WAVES: OSCILLOMETRY BASICS AND INTERPRETATION FOR CLINICAL AND RESEARCH APPLICATION
- MTE25 IMMUNOLOGIC UNDERPINNINGS OF COPD
- MTE32 ADVANCED USE OF ASTHMA BIOLOGICS: A CASE-BASED MASTER CLASS
- MTE9 HAS THE TIME COME TO AIM FOR ASTHMA REMISSION?
- PG10 PULMONARY FUNCTION TESTING: STATE OF THE ART IN 2025
- PG16 CARDIOPULMONARY EXERCISE TESTING: ADVANCES AND APPLICATIONS
- PG17 OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASE 101: DOES MY PATIENT HAVE OCCUPATIONAL LUNG DISEASE?
- PG4 METHODOLOGY FOR INNOVATIVE HEALTH EQUITY RESEARCH: A GRANT PROPOSAL WORKSHOP
- PG7 A HANDS-ON INTRODUCTION TO STUDYING THE LUNG MICROBIOME
- PG8 INNOVATIVE PRECLINICAL MODELS FOR HUMAN LUNG RESEARCH: BRIDGING THE GAP FROM BENCH TO BEDSIDE
Register Today for ATS 2025
Register today for the ATS 2025 International Conference! Don’t miss the opportunity to experience this year’s premier respiratory health conference, May 16-21 in San Francisco. Join your colleagues to learn about the latest pulmonary, critical care, and sleep medicine developments. Not an ATS member? Join today and save on your conference registration!